These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 25252893
21. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, Sanic A, Marrs CF. Diagn Microbiol Infect Dis; 2005 Nov; 53(3):201-8. PubMed ID: 16243477 [Abstract] [Full Text] [Related]
22. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH, Hoffner SE. Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380 [Abstract] [Full Text] [Related]
23. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes? Nguyen HQ, Nguyen NV, Contamin L, Tran THT, Vu TT, Nguyen HV, Nguyen NLT, Nguyen ST, Dang AD, Bañuls AL, Nguyen VAT. Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557 [Abstract] [Full Text] [Related]
25. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. Imperiale BR, Zumárraga MJ, Di Giulio AB, Cataldi AA, Morcillo NS. Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034 [Abstract] [Full Text] [Related]
26. Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa. Millán-Lou MI, Ollé-Goig JE, Tortola MT, Martin C, Samper S. Int J Tuberc Lung Dis; 2016 Feb; 20(2):150-3. PubMed ID: 26792464 [Abstract] [Full Text] [Related]
27. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update. Chaiprasert A, Srimuang S, Tingtoy N, Makhao N, Sirirudeeporn P, Tomnongdee N, Theankeaw O, Charoensook S, Leechawengwongs M, Prammananan T. Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012 [Abstract] [Full Text] [Related]
28. A study on pattern of resistance to second line anti tubercular drugs among multi drug resistant tuberculosis patients. Sharma AK, Gupta N, Kala DK, Patni T, Dixit R, Verma S, Chandran A. Indian J Tuberc; 2018 Jul; 65(3):233-236. PubMed ID: 29933865 [Abstract] [Full Text] [Related]
29. Mechanisms of drug resistance in Mycobacterium tuberculosis. Zhang Y, Yew WW. Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002 [Abstract] [Full Text] [Related]
30. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol]. Chikamatsu K, Aono A, Yamada H, Mitarai S. Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120 [Abstract] [Full Text] [Related]
32. Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa. Olawoye IB, Uwanibe JN, Kunle-Ope CN, Davies-Bolorunduro OF, Abiodun TA, Audu RA, Salako BL, Happi CT. Sci Rep; 2021 Aug 30; 11(1):17387. PubMed ID: 34462504 [Abstract] [Full Text] [Related]
33. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France. Genestet C, Hodille E, Berland JL, Ginevra C, Bryant JE, Ader F, Lina G, Dumitrescu O, Lyon TB Study Group. Int J Antimicrob Agents; 2020 Apr 30; 55(4):105912. PubMed ID: 31991222 [Abstract] [Full Text] [Related]
34. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique. Khosravi AD, Shahraki AH, Dezfuli SK, Hashemzadeh M, Goodarzi H, Mohajeri P. Kaohsiung J Med Sci; 2017 Nov 30; 33(11):550-557. PubMed ID: 29050672 [Abstract] [Full Text] [Related]
35. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region. Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB. PLoS One; 2013 Nov 30; 8(2):e55299. PubMed ID: 23390524 [Abstract] [Full Text] [Related]
36. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test. Jin J, Shen Y, Fan X, Diao N, Wang F, Wang S, Weng X, Zhang W. J Mol Diagn; 2013 Jan 30; 15(1):44-50. PubMed ID: 23159109 [Abstract] [Full Text] [Related]
37. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan. Jou R, Lee WT, Kulagina EV, Weng JY, Isakova AI, Lin WH, Antonova OV, Wu MH, Arslanbaeva LR, Tasi HY, Nosova EY, Zimenkov DV. Infect Genet Evol; 2019 Aug 30; 72():141-146. PubMed ID: 30593924 [Abstract] [Full Text] [Related]
38. Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing. Miotto P, Piana F, Migliori GB, Cirillo DM. New Microbiol; 2008 Jan 30; 31(1):147-50. PubMed ID: 18437855 [Abstract] [Full Text] [Related]
39. Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Microb Drug Resist; 2015 Jun 30; 21(3):315-9. PubMed ID: 25526063 [Abstract] [Full Text] [Related]
40. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee. J Assoc Physicians India; 2006 Mar 30; 54():219-34. PubMed ID: 16800350 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]